summari report sales/ep littl
light rais full year ep guidanc compani report
sale street expect ep
street forecast sale soft
larg attribut inventori japan csi shipment
delay manag maintain sale guidanc ex-
fx growth reflect neg coronaviru sale
impact off-set myday ramp increment revenu
new fertil contract expect sale growth
acceler high-end full year rang
ep line guidanc increas
believ guidanc conserv two key reason fx
assumpt base dec rate current rate add
top-lin nearli bottom-lin
manag assum catch lost sale
believ conserv coronaviru situat get
materi wors increas sale forecast
ex-fx ep estim
result slightli weaker expect report
total sale ex-fx growth
consensu estim softer top-lin reflect continu
inventori destock japan follow stock ahead
consumpt tax increas csi product shipment delay
compani consolid manufactur costa rica estim
neg impact approxim growth
ep slightli consensu
estim due lower revenu higher-than-expect
sg spend pull forward dtc spend relat
paragard quarter tax rate came
estim due benefit employe stock option benefit
maintain total sale guidanc
ex-fx growth reflect lost sale due
coronaviru csi
manag expect off-set strong production/sal
myday increment sale new fertil contract
importantli guidanc assum lost
recoup may prove conserv
spread coronaviru get wors guidanc
assum oper return normal start
meaning materi neg sale impact
coronaviru addit guidanc conserv base fx
rate dec use current fx rate turn
sale headwind closer neutral year
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
top-lin growth expect acceler estim sale impact due
coronaviru depress growth similar impact csi like
reduc overal sale growth closer low-end full-year rang ex-fx sale
growth expect normal plu increment revenu increas myday capac new
fertil contract anticip ex-fx sale growth exceed rang call
manag note restart key account focu hint new private-label custom
contract futur
rais ep guidanc still seem conserv despit unchang top-lin guidanc
manag increas ep outlook rais due lower
expect interest expens reduc tax rate lower
compani continu expect gross oper margin improv slightli yr/yr see coupl
sourc potenti earn upsid first sale loss due coronaviru equat
ep reduct catch sale could provid earn
upsid well second manag conserv assumpt fx point estim ep upsid
nearli math assum current exchang rate howev due currenc volatil
manag conserv base guidanc fx rate dec
us misight launch underway track sale invit
prescrib attend educ program certifi prescrib misight compani note
alreadi patient misight us manag remain confid sale outlook
misight year continu view sale forecast
reason given signific market opportun
price target nc
price target base approxim ep estim risk includ
slower growth contact len market slow misight uptak increas competit stronger
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis tie player nearli share billion global soft contact len
market revenu grew pro forma billion million
